Test your knowledge

Test your knowledge questions:

Question 1 and 2 were obtained from the OASIS Quarterly Q & A January 2022:

1) In situations where a patient cannot demonstrate their ability to take oral or injectable medications, (ex: medications are not in the home) how are codes for M2020 - Management of Oral Medications, and M2030 - Management of Injectable Medications determined?

2) Can a patient take a seated rest break at any time while completing the activity? For example, they start ascending 12 steps but after 5 steps need to stop and rest before completing the remaining 7 steps.

Question 3 and 4 were obtained from the OASIS Quarterly Q & A October 2021:

3) Historic OASIS guidance directs agencies to complete a transfer OASIS (RFA 7 - Transferred to an inpatient facility - patient discharged from agency) under the following unique circumstances:

• A patient dies less than 24 hours after being admitted to an inpatient facility; or

• A patient dies in the emergency room (ER); or

• A patient dies in outpatient surgery.

This means that to meet the new quality measure, Transfer of Health Information to Provider, an agency must send a medication list to the subsequent provider, even for a patient that had died in one of these unique circumstances. Please clarify if this guidance will be modified to accommodate the intent of the Transfer of Health Information to Provider quality measure.

4) If a pressure ulcer/injury is surgically closed with a flap or graft, it should be considered a surgical wound and not a pressure ulcer/injury. If the flap or graft fails, it should still be considered a surgical wound until healed. Is this in reference to ANY point in time that the flap/graft fails? For example, if the area of flap/graft heals and has been 100% re-epithelized for greater than 30 days and a patient subsequently develops a wound at the site of the original flap/graft, would it be considered failed surgical site or would it be considered a pressure ulcer/injury?